Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
ROCKET PHARMACEUTICALS, INC. has filed 936 SEC EDGAR filings since 25 Feb 2004

SEC filing history

Showing 176-200 of 933 matching filings.

Per page
25
Current page
8
144 File 001-36829

144 filing

Filing date
04 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Feb 2025
Reporting date
17 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Feb 2025
Reporting date
21 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Feb 2025
Reporting date
21 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Feb 2025
Reporting date
21 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Feb 2025
Reporting date
21 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
25 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
21 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
21 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
21 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
21 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
21 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Feb 2025
Reporting date
11 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88750

SCHEDULE 13G/A filing

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
05 Feb 2025
Reporting date
27 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .